Position in INDV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,649,724
New position
Shares Held
316,592
first reported quarter
Ownership
0.260%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 87.27921109819579.ToString("F0")%
Shared 0.ToString("F0")%
None 12.720788901804214.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Man Group plc holds $362,228,781 across 31 Drug Manufacturers - Specialty & Generic names. INDV ranks #9 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
783,624 | $92,632,192 | |
| 2 | VTRS |
Viatris Inc
|
4,092,860 | $55,294,537 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
415,909 | $54,791,850 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
77,495 | $45,952,984 | |
| 5 | ALKS |
Alkermes plc.
|
625,046 | $22,101,626 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
208,694 | $16,048,568 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,293,300 | $12,312,216 | |
| 8 | PRGO |
PERRIGO Co plc
|
986,046 | $10,590,134 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,649,724 | 316,592 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||